Optimizing the role of FDG PET–CT for potentially operable metastatic colorectal cancer

被引：0
作者：
A. D. Culverwell
F. U. Chowdhury
A. F. Scarsbrook
机构：
[1] Leeds Teaching Hospitals NHS Trust,Departments of Clinical Radiology and Nuclear Medicine
[2] St James’s University Hospital,Department of Nuclear Medicine
来源：
Abdominal Imaging | 2012年 / 37卷
关键词：
Colonic carcinoma; Rectal carcinoma; Fluorine fluorodeoxyglucose; Positron emission tomography–computed tomography; Metastatic disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Recent treatment advances now allow a realistic chance of cure in selected patients with metastatic colorectal carcinoma (CRC). Accurate pre-treatment staging is crucial to ensure appropriate management by identification of patients with more advanced disease who will not benefit from surgery. 18Fluorine 2-fluoro-2-deoxy-d-glucose positron emission tomography–computed tomography (PET–CT) has a firmly established role in staging, restaging, and recurrence detection of a range of tumors. This article will review the role of PET–CT in patients with CRC with a particular emphasis on optimizing the technique in patients with potentially operable metastatic disease.
引用
收藏
页码：1021 / 1031
页数：10
相关论文
共 254 条
  • [1] Jemal A(2011)Global cancer statistics CA Cancer J Clin 61 69-90
  • [2] Bray F(2004)Colon cancer survival rates with the new American Joint Committee on Cancer Sixth Edition Staging J Natl Cancer Inst 96 1420-1425
  • [3] Center MM(2008)Impact of positron emission tomography/computed tomography and positron emission tomography (PET) alone on expected management of patients in cancer; initial results from the national oncologic PET registry J Clin Oncol 26 2155-2161
  • [4] O’Connell JB(2002)PET diagnostic accuracy: improvement with in-line PET–CT system: initial results Radiology 225 575-581
  • [5] Maggard MA(2004)Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy- J Clin Oncol 22 4357-4368
  • [6] Ko CY(2006)-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET Radiology 238 405-422
  • [7] Hilner BE(2003)Integrated PET/CT: current applications and future directions Surg Oncol Clin N Am 12 165-192
  • [8] Siegel BA(2008)A critical review of the major indicators of prognosis after resection of hepatic metastases from colorectal carcinoma Oncologist 13 51-64
  • [9] Liu D(2003)Expanding criteria for resectability of colorectal liver metastases Br J Surg 90 567-574
  • [10] Hany TF(2008)Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases Eur J Nucl Med Mol Imaging 35 1323-1829
12345678910